Advisor Partners LLC Repligen Corp Transaction History
Advisor Partners LLC
- $1.42 Billion
- Q2 2022
A detailed history of Advisor Partners LLC transactions in Repligen Corp stock. As of the latest transaction made, Advisor Partners LLC holds 1,577 shares of RGEN stock, worth $230,131. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,577
Previous 1,233
27.9%
Holding current value
$230,131
Previous $232,000
10.34%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding RGEN
# of Institutions
506Shares Held
58.7MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$964 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$741 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$279 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$237 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.1B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....